FDA Inspection 573197 — South Texas Blood & Tissue Center

South Texas Blood & Tissue Center — FEI 1676815

The FDA completed an inspection of South Texas Blood & Tissue Center on Mar 5, 2009 in San Antonio, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 5, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
San Antonio, TX (United States)

Citations

IDCFRDescription
1247021 CFR 1271.350(a)(2)15 day reporting timeframe

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.